Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of different doses of oral furosemide on urine volume in peritoneal dialysis patients
TCTR20200723004Phase 3Not yet recruiting
- Sponsor
- Division of nephrology
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of furosemide in end-stage kidney disease (ESKD), sponsored by Division of nephrology. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
furosemide
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on TCTR20200723004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200723004.